Issue 41 - The Cancer Letter

Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.

SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.

LOGIN SUBSCRIBE NOW

SEARCH DATE

SEARCH TEXT

Cancel

OK

Cancel

OK

Delete Account

Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below

Iowa’s Mark Burkard sees a role for data science in bringing clinical trials to rural clinics

At his 25-year “anniversary party,” Pazdur invites Califf and past FDA commissioners to talk about political interference

FDA extends shelf-life for IV fluids in shortage after Hurricane Helene

Addressing high cancer mortality in Native Hawaiian and Pacific Islander populations
A call for equity in cancer research

“Less Radical” podcast: Resistance to change, a data scandal

In Brief

UChicago receives $75M from AbbVie Foundation for construction of the cancer care and research pavilion

Longevity Consortium receives $45M grant

Ruling changes NY law, restores oncologists ability to provide supportive therapies in-office

UF Health Cancer Center rolls out mobile cancer screening vehicle

UNM CCC receives three-year reaccreditation from the Commission on Cancer

Clinical Roundup

NCCS releases “2024 State of Cancer Survivorship” data

Latino enclaves in U.S. have less access to health care

Drugs & Targets

FDA approves Scemblix for newly diagnosed CML patients

Pangea Biomed, OHSU Knight Cancer Institute collaborate to improve cancer therapy precision

NCI Trials

NCI Trials for November 2024

Recent Issues

Renew today!

Subscriber content

Never miss an issue!

Login